NASDAQ:DERM - US48115J1097 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -8.74M | -14.67M | -3.85M | -29.63M | -43.99M | |||
Depreciation Amortization | 3.92M | 3.42M | 3.77M | 4.28M | 2.47M | |||
Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 1.57M | |||
Change In Working Capital | -3.06M | -3.77M | -1.66M | 6.19M | 14.71M | |||
Interest Paid | 2.85M | 2.01M | 1.13M | 990.00K | N/A | |||
Taxes Paid | 71.00K | 125.00K | 181.00K | 170.00K | 160.00K | |||
Other non cash items | 5.16M | 5.89M | 6.98M | 5.63M | 23.06M | |||
OPERATING CASH FLOW | -2.71M | -9.13M | 5.24M | -13.53M | -2.18M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
INVESTING CASH FLOW | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | 3.13M | 8.75M | -8.95M | 16.90M | 5.05M | |||
Stock Issued/Repurchased | 571.00K | 416.00K | 121.00K | 140.00K | 51.51M | |||
Other Financing Activity | 10.39M | 7.83M | 4.02M | -590.00K | -3.55M | |||
FINANCING CASH FLOW | 14.09M | 16.99M | -4.80M | 16.46M | 53.02M | |||
CHANGE IN CASH | -3.62M | -7.13M | -4.56M | -17.07M | 40.84M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | -2.71M | -9.13M | 5.24M | -13.53M | -2.18M | |||
Capital Expenditure | N/A | -15.00M | -5.00M | -20.00M | -10.00M | |||
FREE CASH FLOW | -17.71M | -24.13M | 240.00K | -33.53M | -12.18M |
All data in USD